Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Core EBITDA Growth

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 564.5847.26-

What is the latest Core EBITDA Growth ratio of ONESOURCE SPECIALTY PHARMA ?

The latest Core EBITDA Growth ratio of ONESOURCE SPECIALTY PHARMA is 564.58 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025564.58
Mar202447.26
Mar2023-

How is Core EBITDA Growth of ONESOURCE SPECIALTY PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 564.58
1,094.63
Mar2024 47.26
0
Mar2023 0 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare Core EBITDA Growth ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹20,034.9 Cr -0.8% 21.8% 10.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,859.0 Cr 4.2% 5.3% 1.1% Stock Analytics
DIVIS LABORATORIES ₹176,618.0 Cr 3.4% 12.6% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,718.0 Cr 2.2% 4.1% 28% Stock Analytics
CIPLA ₹107,722.0 Cr 2% 11.5% -13.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,081.0 Cr -6.2% 5.1% 9.5% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

-0.8%

21.8%

10.8%

SENSEX

-0.4%

7.1%

-4%


You may also like the below Video Courses